-
A New TGF-β Mimetic, XEP™-716 Miniprotein™, Exhibiting Regenerative Properties Objectivized by Instrumental Evaluation Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-19 Hanane Chajra, Thibaut Saguet, Corinne Granger, Lionel Breton, Pedro Contreiras Pinto, Mickael Machicoane, Jean Marc Le Doussal
-
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-17 Matthias Augustin, Alice B. Gottlieb, Mark Lebwohl, Andreas Pinter, Richard B. Warren, Luis Puig, Rhys Warham, Jérémy Lambert, Susanne Wiegratz, Balint Szilagyi, Andrew Blauvelt
-
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-16 Andrew Blauvelt, Robert R. McLean, Silky W. Beaty, Adam P. Sima, Robert Low, Jeffrey L. Stark, Laura McClung, Jerry Bagel
-
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-16 Philip J. Mease, Andrew Blauvelt, Adam P. Sima, Silky W. Beaty, Robert Low, Braulio Gomez, Marie Gurrola, Mark G. Lebwohl
-
Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-16 Ian M. Catlett, Lu Gao, Yanhua Hu, Subhashis Banerjee, James G. Krueger
-
Exploring the Intersection of Body Dysmorphic Disorder (BDD) and Dermatological Conditions: A Narrative Review Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-12 Vivian Li, Kelly Frasier, Emily Woolhiser, Kathleen Daly, Sara Christoforides, Courtnee Harpine, Karina Stech, Stefany Acosta, Edwin D. Lephart
This narrative literature review examined the intricate relationship between body dysmorphic disorder (BDD) and dermatological conditions, with a brief focus on those characterized by conspicuous skin irregularities such as acne vulgaris, psoriasis, and vitiligo. Highlighting the significant prevalence of BDD among individuals afflicted with dermatological issues, our analysis illuminated the profound
-
Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-12 Mark G. Lebwohl, April W. Armstrong, Andrew F. Alexis, Edward L. Lain, Abby A. Jacobson
-
Cutaneous Manifestations in Patients with Dermatomyositis, Are They Only Skin Deep? Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-12 Stephanie McKee, Jason Xenakis, Harriet Makin, Chris Marshall, Randall Winnette, Rohit Aggarwal, Sarah Knight
-
Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-10 Jennifer Fu, Alexander Egeberg, Susan Holmes, Sergio Vano-Galvan, Martin Steinhoff, Roger Edwards, Gianluca Bonfanti, Ranjit Nagra, Robert Wolk, Helen Tran, Ernest Law
-
A Review of Hidradenitis Suppurativa in Special Populations: Considerations in Children, Pregnant and Breastfeeding Women, and the Elderly Dermatol. Ther. (IF 3.5) Pub Date : 2024-09-04 Claire S. Chung, Sarah E. Park, Jennifer L. Hsiao, Katrina H. Lee
Hidradenitis suppurativa (HS) is a chronic skin condition that significantly impacts patients’ quality of life. HS is often challenging to treat. In this review, we discuss the unique characteristics of HS in four special populations: children, the elderly, pregnant individuals, and breastfeeding mothers. In children, diagnosis may be delayed due to atypical and early HS disease presentations. HS management
-
Vorasidenib-Induced Trichomegaly and Hypertrichosis: a New Side Effect in a Patient with Diffuse Astrocytoma Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-31 Michela Starace, Stephano Cedirian, Luca Rapparini, Francesca Bruni, Bianca Maria Piraccini
-
Efficacy of a Multi-lamellar Emulsion Containing a Synthetic Sphingosine Kinase 1 Activator and Pseudoceramide in Patients with Atopic Dermatitis: A Randomized Controlled Trial Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-30 So Yeon Lee, Jin Seo Park, Daehwan Kim, Wonseok Jeong, Chenghwan Hwang, Hye One Kim, Chun Wook Park, Bo Young Chung
-
A 3-Year Experience with Tildrakizumab Treatment for Patients with Plaque Psoriasis in Clinical Practice Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-27 Martina Burlando, Ilaria Salvi, Aurora Parodi, Emanuele Cozzani
-
Prospective Clinical Study: Full-Body Blue Irradiation in the Treatment of Atopic Dermatitis Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-24 Magdalena Sadowska, Joanna Narbutt, Daniel Nolberczak, Magdalena Ciążyńska, Małgorzata Skibińska, Dorota Sobolewska-Sztychny, David Aubert, Aleksandra Lesiak
-
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-23 April W. Armstrong, Peter Foley, Yan Liu, Megan Miller, Rachel E. Teneralli, Anthony Bewley, Kenneth B. Gordon, Kim A. Papp, Chenglong Han
-
Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-22 Ahmed Ameen, Ahmed Al Dhaheri, Ashraf M. Reda, Ayman Alnaeem, Fatima Al Marzooqi, Fatima Albreiki, Huda Rajab Ali, Hussein Abdel Dayem, Jawaher Alnaqbi, Mariam Al Zaabi, Mohammed Ahmed, Georg Stingl, Muna Al Murrawi
-
Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Cross-Sectional Survey of Dermatologists Within the Asia–Pacific Region Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-20 Chia-Yu Chu, Yung Chan, Siriwan Wananukul, Hao Cheng, Nisha Suyien Chandran, Ramesh Bhat, Sang Wook Son, Han-Fang Liao, Sean Gardiner, Qi Qing Ng, See-Hwee Yeo, Sophie Bozhi Chen, Yoko Kataoka
-
Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-17 Luis Puig, Antonio Costanzo, Elke M. G. J. de Jong, Tiago Torres, Richard B. Warren, Robert Wapenaar, Sven Wegner, Patricia Gorecki, Talia Gramiccia, Maria Jazra, Jozefien Buyze, Curdin Conrad
-
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-17 Kenneth B. Gordon, Andrew Blauvelt, Hervé Bachelez, Laura C. Coates, Filip E. Van den Bosch, Blair Kaplan, Willem Koetse, Doug G. Ashley, Ralph Lippe, Ranjeeta Sinvhal, Kim A. Papp
-
Extended Half-life Antibodies: A Narrative Review of a New Approach in the Management of Atopic Dermatitis Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-15 Orhan Yilmaz, Tiago Torres
-
Restoration of the Ultrastructural Integrity of the Dermal Collagen Network by 12-Week Ingestion of Special Collagen Peptides Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-16 Dorothee Dähnhardt, Stephan Dähnhardt-Pfeiffer, Dörte Segger, Burkhard Poeggeler, Gunter Lemmnitz
-
Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-12 Ali Elabbasi, Ahmed Kadry, Warren Joseph, Boni Elewski, Mahmoud Ghannoum
-
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-10 Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, Jose-Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline Pierce, Helena Agell, Sonja Ständer
-
Highlights of Gene and Cell Therapy for Epidermolysis Bullosa and Ichthyosis Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-07 Stefanos A. Koutsoukos, Ganna Bilousova
-
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-08 Mark G. Kirchhof, Vimal H. Prajapati, Melinda Gooderham, Chih-ho Hong, Charles W. Lynde, Catherine Maari, Irina Turchin, Kim A. Papp
Oral Janus kinase inhibitors (JAKi), a class of advanced targeted systemic therapy, have demonstrated efficacy and safety in the treatment of moderate-to-severe atopic dermatitis (AD). Like other small molecules, oral JAKi have the potential for off-target effects including laboratory-related adverse events (AEs). Product labels for oral JAKi recommend an initial laboratory assessment and follow-up
-
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-07 Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, Jonathan I. Silverberg
-
Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia–Pacific Region: A Cross-sectional Survey Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-05 Chia-Yu Chu, Yung Chan, Siriwan Wananukul, Hao Cheng, Nisha Suyien Chandran, Ramesh Bhat, Sang Wook Son, Han-Fang Liao, Sean Gardiner, Qi Qing Ng, See-Hwee Yeo, Sophie Bozhi Chen, Yoko Kataoka
-
Assessing Participants’ Experiences with Vitiligo from Patient Interviews Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-05 Amit G. Pandya, Theresa Amoloja, Kristen Bibeau, Dana DiBenedetti, Katherine Kosa, Kathleen Butler, Deanna Kornacki, Khaled Ezzedine
-
Treatment of Epidermolysis Bullosa and Future Directions: A Review Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-02 Sorina Danescu, Mircea Negrutiu, Cristina Has
-
Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search Dermatol. Ther. (IF 3.5) Pub Date : 2024-08-01 Lluís Puig, Hideki Fujita, Diamant Thaçi, Min Zheng, Ana Cristina Hernandez Daly, Craig Leonardi, Mark G. Lebwohl, Jonathan Barker
-
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-30 April W. Armstrong, Matthias Augustin, Jennifer L. Beaumont, Tan P. Pham, Stacie Hudgens, Kenneth B. Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M. Kisa, Subhashis Banerjee, Kim A. Papp
-
An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-29 Hidehisa Saeki, Yukihiro Ohya, Naoko Baba, Tomomi Imamura, Daisuke Yokota, Hidetsugu Tsubouchi
-
Clinical Characteristics and Disease Burden of Patients with Moderate-to-Severe Generalized Pustular Psoriasis Flares in Taiwan Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-30 Chun-Wei Lu, Chien-Yu Tseng, Chuang-Wei Wang, Shang-Hung Lin, Chun-Bing Chen, Rosaline Chung-Yee Hui, Ching-Chi Chi, Yu-Huei Huang, Chih-Hung Lee, Fang-Ju Lin, Wen-Hung Chung
-
Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-30 Kristen Bibeau, Kathleen Butler, Mingyue Wang, Konstantina Skaltsa, Iltefat H. Hamzavi
-
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-30 April W. Armstrong, H. Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, Jonathan I. Silverberg
-
Comparison of Drug-Free Remission after the End of Phase III Trials of Three Different Anti-IL-23 Inhibitors in Psoriasis Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-29 Chang-Yu Hsieh, Francis Li-Tien Hsu, Tsen-Fang Tsai
-
Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-27 Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, Moshe Ben-Shoshan, Elizabeth Laws, Jennifer Maloney, Deborah Bauer, Allen Radin, Melanie Makhija
-
Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-22 Tiago Torres, Maria João Cruz, Margarida Gonçalo, Paulo Filipe, Bruno Duarte, João Alves, José Miguel Alvarenga, Gilberto Rosa, Duarte Flor, José Ramos, Diogo Sousa, Aureliu Rosca, César Magalhães, Cristina Claro, Joana Rocha, Catarina Vilarinho, Fernando Mota, Alberto Mota, Maria João Paiva Lopes
-
How Digital Solutions Might Provide a World of New Opportunities for Holistic and Empathic Support of Patients with Hidradenitis Suppurativa Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-23 Annie Boucher, Martin Peters, Graham B. Jones
-
Biomarkers in Cutaneous Keratinocyte Carcinomas Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-20 Erica Montano, Neal Bhatia, Jelena Ostojić
-
Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-16 Miguel Mansilla-Polo, Daniel Morgado-Carrasco
Introduction The risk of infections associated with biological drugs (BD) and Janus kinase inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth of studies that evaluate both pharmacological groups together and, furthermore, compare them. Here, we review the risk of infections associated with BD and JAKi used in dermatology. Methods A narrative review was performed
-
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-15 Jennifer Soung, Vivian Laquer, Joseph F. Merola, Angela Moore, Hany Elmaraghy, Chaoran Hu, Maria Lucia Buziqui Piruzeli, Evangeline Pierce, Esther Garcia Gil, Abel D. Jarell
-
Bridging the Gap: Comparing Patient-Clinician Views on Treatment Goals and Communication in the Management of Atopic Dermatitis Within the Asia–Pacific Region Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-15 Chia-Yu Chu, Yung Chan, Siriwan Wananukul, Hao Cheng, Nisha Suyien Chandran, Ramesh Bhat, Sang Wook Son, Han-Fang Liao, Sean Gardiner, See-Hwee Yeo, Sophie Bozhi Chen, Qi Qing Ng, Yoko Kataoka
-
Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-12 Adina Eichner, Yahya Mrestani, Martin Hukauf, Johannes Wohlrab
-
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-13 Gil Yosipovitch, Peter Lio, Franz J. Legat, Raj Chovatiya, Mette Deleuran, Evangeline Pierce, Marta Casillas, Yuxin Ding, Fan E. Yang, Laia Bardolet, Sonja Ständer
-
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-12 Eric L. Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F. Eichenfield
-
Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-08 Stephanie McKee, Jason Xenakis, Harriet Makin, Chris Marshall, Randall Winnette, Rohit Aggarwal, Sarah L. Knight
-
Hair Shaft Abnormalities as a Dermoscopic Feature of Mycosis Fungoides: Pilot Results Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-03 Magdalena Jasińska, Joanna Czuwara, Nino Lortkipanidze, Agnieszka Michalczyk, Barbara Borkowska, Patrycja Gajda-Mróz, Marta Kurzeja, Małgorzata Olszewska, Lidia Rudnicka, Adriana Rakowska
-
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-02 Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero
-
Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-02 Ada Trindade de Almeida, Carla de Sanctis Pecora, Elisa R. Marques, Leticia Contin, Camila Trindade de Almeida, Ana Lúcia da Cunha
-
Association Between Natural Hair Color, Race, and Alopecia Dermatol. Ther. (IF 3.5) Pub Date : 2024-07-02 Kanika Kamal, David Xiang, Katherine Young, David E. Fisher, Arash Mostaghimi, Nicholas Theodosakis
Introduction Limited epidemiologic data has suggested direct associations between hair pigment, race, and incidence of alopecia areata (AA). Here, we examine the relationship between natural hair color, race, and the lifetime risk alopecia. Methods In this case–control study, we included UK Biobank patients of all races and self-reported hair color with diagnoses of AA, androgenetic alopecia (AGA)
-
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-27 Bernhard Korge, Olivier Vanhooteghem, Charles W. Lynde, Alena Machovcova, Marc Perrussel, Elisavet Lazaridou, Claudio Marasca, David Vidal Sarro, Ines Duenas Pousa, Frederik Fierens, Paulette Williams, Saori Shimizu, Tanja Heidbrede, Richard B. Warren
-
Psoriasis and Sleep Disturbance: A US Population-Based Study Using the NHANES Database Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-28 Payton Smith, Joy Q. Jin, Riley K. Spencer, Kareem G. Elhage, Chandler E. Johnson, Kathryn Haran, Allison Kranyak, Mitchell S. Davis, Marwa Hakimi, Aric A. Prather, Katie L. Stone, Wilson Liao, Tina Bhutani
Introduction Psoriasis, a chronic inflammatory skin condition, affects approximately 3.0% of the US population, with patients often experiencing significant sleep disturbances. These disturbances include a higher prevalence of conditions such as obstructive sleep apnea, restless leg syndrome, and insomnia. Given the additional risks for cardiovascular disease, metabolic disorders, and depression linked
-
Disease Course, Treatment Patterns and Goals Among Patients with Non-segmental Vitiligo Across Europe and the United States Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-26 David Rosmarin, Ahmed M. Soliman, Simran Marwaha, James Piercy, Heidi S. Camp, Peter Anderson, Khaled Ezzedine
-
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-26 Peter A. Lio, April Armstrong, Jan Gutermuth, Audrey Nosbaum, Howard Sofen, Esther Garcia Gil, Marta Casillas, Sherry Chen, Luna Sun, Evangeline Pierce, Hany Elmaraghy, Zach Dawson, Tiago Torres
-
Psychodermatology of Chronic Pruritus: An Overview of the Link Between Itch and Distress Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-24 Bárbara R. Ferreira, Olivia M. Katamanin, Mohammad Jafferany, Laurent Misery
-
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-25 Lyn Guenther, Irina Turchin, Ron Vender, Lorne E. Albrecht, Catherine Maari, Howard Yanofsky, Vimal H. Prajapati
-
A Systematic Review and Meta-analysis of Mobile Health Applications and Telemonitoring in Atopic Dermatitis Self-Management Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-22 Ivan Cherrez-Ojeda, Karla Robles-Velasco, María F. Osorio, Ana Ormaza Vera, Zouina Sarfraz, Azza Sarfraz, Annia Cherrez, Sofia Cherrez, Jorge Mario Sanchez Caraballo
-
Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-22 Vrinda Madan, Laura I. Ortiz-López, Goranit Sakunchotpanit, Ryan Chen, Krithika Nayudu, Vinod E. Nambudiri
-
Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis Dermatol. Ther. (IF 3.5) Pub Date : 2024-06-22 Rahul Masson, Justine Seivright, Tristan Grogan, Swetha Atluri, Iltefat Hamzavi, Marcia Hogeling, Vivian Y. Shi, Jennifer L. Hsiao